Contrasting Vivani Medical (NASDAQ:VANI) & Zoetis (NYSE:ZTS)

Vivani Medical (NASDAQ:VANIGet Free Report) and Zoetis (NYSE:ZTSGet Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation.

Insider and Institutional Ownership

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 92.8% of Zoetis shares are owned by institutional investors. 46.4% of Vivani Medical shares are owned by company insiders. Comparatively, 0.2% of Zoetis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Vivani Medical and Zoetis’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Vivani Medical N/A -293.64% -79.49%
Zoetis 28.21% 57.19% 19.53%

Risk and Volatility

Vivani Medical has a beta of 3.07, suggesting that its share price is 207% more volatile than the S&P 500. Comparatively, Zoetis has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Vivani Medical and Zoetis, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivani Medical 1 1 1 0 2.00
Zoetis 1 7 6 0 2.36

Vivani Medical currently has a consensus price target of $4.00, suggesting a potential upside of 210.08%. Zoetis has a consensus price target of $160.18, suggesting a potential upside of 27.31%. Given Vivani Medical’s higher possible upside, analysts plainly believe Vivani Medical is more favorable than Zoetis.

Earnings and Valuation

This table compares Vivani Medical and Zoetis”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Vivani Medical N/A N/A -$23.49 million ($0.45) -2.87
Zoetis $9.26 billion 5.99 $2.49 billion $5.94 21.18

Zoetis has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Zoetis, indicating that it is currently the more affordable of the two stocks.

Summary

Zoetis beats Vivani Medical on 10 of the 13 factors compared between the two stocks.

About Vivani Medical

(Get Free Report)

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

About Zoetis

(Get Free Report)

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.